Founded in 2007, Bora Pharmaceuticals continues to gain industry trust, significantly expanding market penetration through premium CDMO services. Our distinctive dual-engine strategy integrates scalable, high-quality CDMO growth with innovative drug development focused on specialty pharma and rare diseases. Strategic investments in manufacturing capabilities, operational excellence, and specialized talents are the pillars that sustain our valued partnerships in the industry. At Bora, we take pride in accelerating access to transformative treatments by enabling genuine, decisive progress.